Company Filing History:
Years Active: 2025
Title: Shilpi Khare: Innovator in Cancer Treatment
Introduction
Shilpi Khare is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of cancer treatment, particularly in the development of combination therapies for KRas G12C cancers. Her innovative work is paving the way for more effective treatment options for patients in need.
Latest Patents
Shilpi Khare holds 1 patent related to her groundbreaking research. The patent, titled "Combination therapies," focuses on methods for treating cancer by administering a combination of a SOS1 inhibitor and a KRas G12C inhibitor. This invention includes pharmaceutical compositions and kits designed for effective cancer treatment.
Career Highlights
Khare is currently employed at Mirati Therapeutics, Inc., where she continues to advance her research in cancer therapies. Her work is characterized by a commitment to improving patient outcomes through innovative treatment strategies.
Collaborations
Shilpi collaborates with notable colleagues, including Jacob Haling and John Michael Ketcham. These partnerships enhance her research efforts and contribute to the development of effective cancer therapies.
Conclusion
Shilpi Khare's contributions to cancer treatment through her innovative patent and collaborative efforts highlight her role as a leading inventor in the field. Her work is essential in the ongoing fight against cancer, offering hope for improved therapies.